Drug ingestions in children 10-14 years old: an old problem revisited

Wendy Pomerantz1, Michael Gittelman, Sarah Farris

  • 1Cincinnati Children's Hospital, Division of Emergency Medicine, Cincinnati, OH 45229, USA. wendy.pomerantz@cchmc.org

Insights

Hospitalizations for drug ingestions among 10-14 year olds decreased significantly. However, more males are ingesting drugs, particularly psychiatric medications like SSRIs, indicating a shift in ingestion patterns.

Area of Science:

  • Pediatric Toxicology
  • Public Health Surveillance
  • Adolescent Health

Background:

  • Drug ingestions in children are a significant public health concern.
  • Understanding trends in pediatric drug ingestions is crucial for prevention and intervention.

Purpose of the Study:

  • To analyze changes in the rates and patterns of drug ingestions among 10-14 year old children.
  • To identify demographic and substance-related shifts in pediatric drug ingestions over time.

Main Methods:

  • Retrospective chart review of hospitalized 10-14 year olds.
  • Comparison of data from 1993-1995 and 2000-2004.
  • Statistical analysis using Odds Ratios and Chi-square tests.

Main Results:

  • Overall hospitalization rates for drug ingestions decreased from 92.8 to 63.3 per 100,000 children/year.
  • The proportion of male ingestions increased from 14.2% to 26.3%.
  • Psychiatric medication ingestions rose from 27.0% to 38.9%, with an increase in Selective Serotonin Reuptake Inhibitors (SSRIs) and a decrease in tricyclics.

Conclusions:

  • Hospitalization rates for drug ingestions in 10-14 year olds have declined.
  • There has been a notable shift in the types of drugs ingested, with a rise in psychiatric medications, especially SSRIs.
  • An increasing proportion of males are involved in drug ingestions, highlighting a changing demographic profile.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...